表观遗传学药物治疗骨髓增生异常综合征贫血
摘要
骨髓增生异常综合征(myelodysplasticsyndrome,MDS)是一组起源于造血髓系定向干细胞或多能干细胞的克隆性疾病,主要特征是病态造血和高危演变为急性髓系白血病(AML)。2001年世界卫生组织(WHO)将其归类于髓系造血细胞肿瘤。2004年美国国家癌症中心流行病学调查和最终结果(SEER)统计资料表明MDS的发病率为3.8/10万人。
出处
《内科理论与实践》
2010年第4期291-296,共6页
Journal of Internal Medicine Concepts & Practice
参考文献33
-
1Rollison DE,Howlader N,Smith MT,et al.Epidemiology of myelodysplasfic syndromes and chronic myeloproliferative disorders in the United States,2001-2004,using data from the NAACCR and SEER programs[J].Blood,2008,112(1):45-52.
-
2Sekeres MA.The epidemiology of myelodysplastic syndromes[J].Hematol Oncol Clin North Am,2010,24 (2):287-294.
-
3Hellstrom-Lindberg E,Gulbrandsen N,Lindberg G,et al.A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor:significant effects on quality of life[J].Br J Haematol,2003,120(6):1037-1046.
-
4Gary G,Alan F.Myelodysplastic syndrome[M] //Goldman:Cecil Medicine.23rd ed.Los Angeles:Saunters,an imprint of elsevier,Co.Press.2007:1387-1390.
-
5Hellstrom-Lindberg E,Malcovati L Supportive care,growth factors,and new therapies in myelodysplastic syndromes[J].Blood Rev,2008,22(2):75-91.
-
6Tehranchi R,Invernizzi R,Grandien A,et al.Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes[J].Blood,2005,106(1):247-253.
-
7Otsuki T,Nagakura S,Wang J,et al.Tumor necrosis factor-α and CD95 ligation suppress erythropoiesis in Fanconi anemia C gent knockout mice[J].J Cell Physiol,1999,179(1):79-86.
-
8Porta MG,Malcovati L,Galli A,et al.Mitochondrial ferritin expression and clonality of hematopoiesis in patients with refractory anemia with ringed sideroblasts[J].Blood,2005,106(11):3444.
-
9Issa JP.Epigenetic changes in the myelodysplastic syndrome[J].Hematol Oncol Clin North Am,2010,24 (2):317-330.
-
10Quesnel B,Guillerm G,Vereecque R,et al.Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression[J].Blood,1998,91(8):2985-2990.
二级参考文献6
-
1Uchida T,Kinoshita T,Nagai H,et al.Hypermethylation of the P15^INK4B gene in myelodysplastic syndromes.Blood,1997;90(4):1403-1409.
-
2Preisler HD,Li B,Chen H,et al.P15^INK4B gene methylation and expression in normal,myelodysplastic,and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients.Leukemia,2001;15(10):1589-1595.
-
3Silverman LR,Holland JF,Weinberg RS,et al.Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.Leukemia,1993;7(Suppl 1):21-29.
-
4Daskalakis M,Nguyen TT,Nguyen C,et al.Demethylation of a hypermethylated P15INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment.Blood,2002;100(8):2957-2964.
-
5任立敏,杜红玲,朱强,石永进,陈华,武淑兰.体外试验诱导白血病细胞p15^(INK4B)基因重新表达[J].中华内科杂志,2002,41(11):762-765. 被引量:1
-
6佟红艳,林茂芳.三氧化二砷诱导人骨髓增生异常综合征细胞株MUTZ-1细胞p15INK4B基因表达的研究[J].中华血液学杂志,2002,23(12):638-641. 被引量:17
共引文献8
-
1寿倍明,陈宝安,刘德龙.去甲基化在白血病上的研究进展[J].中国实验血液学杂志,2008,16(5):1247-1250. 被引量:11
-
2侯理(综述),刘霆(审校).骨髓增生异常综合征的化疗[J].国际输血及血液学杂志,2010(3):229-233.
-
3李空飞(综述),佟红艳(审校).以甲基化转移酶抑制剂为基础的联合方案治疗恶性血液病的研究进展[J].国际输血及血液学杂志,2011,34(6):546-548. 被引量:3
-
4罗朝蕊,刘霆.骨髓增生异常综合征去甲基化药物临床反应的生物学标志研究进展[J].华西医学,2012,27(5):779-782. 被引量:1
-
5徐佳,宋强.骨髓增生异常综合征患者RASSF1A基因启动子区甲基化及基因表达的缺失[J].山东大学学报(医学版),2013,51(2):65-69.
-
6周冰(综述),马梁明,梁立新(审校).地西他滨在恶性血液肿瘤治疗中的应用[J].肿瘤研究与临床,2013,25(2):136-138. 被引量:5
-
7姚亚洲,李小妮,郑引索.含三氧化二砷方案治疗复发难治性非M3急性非淋巴细胞白血病45例疗效观察[J].现代肿瘤医学,2015,23(20):3030-3032. 被引量:3
-
8ZHANG Miao,ZHANG Jia-yi,SUN Ming-qian,LU Peng,LIU Jian-xun.Realgar(α-As_(4)S_(4))Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation[J].Chinese Journal of Integrative Medicine,2022,28(3):281-288. 被引量:2
-
1邵秀茹,梁红,关晓军,刘晶,黄湛,王巧玲,赵娜,贡铁军,李蕊,展昭民,张伯龙,马军.地西他滨治疗中、高危骨髓增生异常综合征患者的临床研究[J].中华血液学杂志,2011,32(11):789-791. 被引量:17
-
2张勇,陈洁平.骨髓增生异常综合征的表观遗传治疗[J].重庆医学,2009,38(23):3021-3025. 被引量:3
-
3张勇,陈洁平.骨髓增生异常综合征的表观遗传治疗[J].重庆医学,2010,39(10):1292-1296. 被引量:1
-
4高春记,宋增璇.髓系造血生长因子与临床应用[J].国外医学(输血及血液学分册),1991,14(2):89-91. 被引量:3
-
5关于召开2016年中国慢性病大会的通知[J].中国慢性病预防与控制,2016,24(8):599-599.
-
6崔兴(综述),徐瑞荣(综述),王军强(综述).骨髓增生异常综合征的治疗新策略——表观基因调控[J].白血病.淋巴瘤,2009,18(10):633-635. 被引量:2
-
7刘庆清,王荣丽.组蛋白去乙酰化酶与支气管哮喘的关系[J].山东医药,2016,56(37):110-112. 被引量:2
-
8陈延伟,杨炯,黄毅.慢性阻塞性肺病外周血单个核细胞中的组蛋白去乙酰化酶活性与全身炎症的关系[J].武汉大学学报(医学版),2009,30(4):502-506. 被引量:4
-
9孙乃同,周茉,盛薇薇,单学赟,王纯斌,杨小燕,周燕,唐云龙,邵钰.国产地西他滨联合CAG方案治疗高危骨髓增生异常综合征的疗效[J].实用临床医药杂志,2016,20(1):151-152. 被引量:6
-
10陈芳源.对骨髓增生异常综合征诊断和治疗指南的认识[J].诊断学理论与实践,2005,4(5):362-364. 被引量:1